Ultragenyx Gene Therapy Becomes First FDA-Approved Treatment for Ultra-Rare Disease Read More August 20, 2026
Merck, Moderna Personalized mRNA Cancer Therapy Achieves a First for Melanoma Read More August 19, 2026